Stefanie Pluschkell is the Founder and CEO of InScope Coaching & Consulting LLC, providing executive leadership and career coaching as well as consulting services to corporations, academic institutions, non-profit scientific organizations, and individuals. She has over 20 years of experience in the biopharmaceutical industry and currently serves as Senior Fellow of the National Institute for Innovation in Manufacturing Biotherapeutics (NIIMBL), a public-private partnership whose mission is to accelerate...Read more
Please fill out this form to initiate the registration process. This workshop is open to university faculty/professors. Once we have confirmed your faculty status we will then send you detail for the faculty workshop.
Francesco received his PhD in mechanical and industrial engineering at the University of Brescia, having spent 6 months at MIT as a visiting student, and his bachelors and masters in physics at the University of Milan. After focusing on molecular dynamics simulations, he started pursuing a career in quantum computing as a postdoctoral fellow at the University of L’Aquila, where he was collaborating with the IBM research team in Zurich, as a quantum software developer at Multiverse Computing, and finally as a quantum solutions engineer at Zapata Computing, where he helps enterprises tackle...Read more
Francesco received his PhD in mechanical and industrial engineering at the University of Brescia, having spent 6 months at MIT as a visiting student, and his bachelors and masters in physics at the University of Milan. After focusing on molecular dynamics simulations, he started pursuing a career in quantum computing as a postdoctoral fellow at the University of L’Aquila, where he was collaborating with the IBM research team in Zurich, as a quantum software developer at Multiverse Computing, and finally as a quantum solutions engineer at Zapata Computing,...Read more
Gregg Nyberg is a biopharmaceutical executive with over twenty-five years of experience in process development, clinical manufacturing, technology transfer and commercialization. He is currently Chief Technology Officer at Landmark Bio, where he is responsible for translational research, process and analytical development, digital technologies and innovation, engineering, supply chain and clinical manufacturing for advanced therapies including cell and gene therapy. Prior to joining Landmark, Gregg served in multiple leadership roles at Merck, Amgen...Read more
Aine Hanly, Ph.D., serves as Chief Technology Officer at Vir Biotechnology, where she is responsible for overseeing the Company’s technical operations. Her purview includes product and process development, supply chain, manufacturing, quality and CMC strategy for multi-modality products addressing the world’s most serious infectious diseases including COVID-19, hepatitis B virus, influenza A and human immunodeficiency virus. Aine’s career in the biomanufacturing...Read more
Dana Andersen joined Denali Therapeutics in 2018 as the Chief Technical and Manufacturing Officer and is responsible for overseeing the development of manufacturing processes, production, quality control & assurance and clinical supply to support the Denali portfolio.
Previously, he worked at Genentech for nearly 23 years, most recently as Vice President and Global Head of Technical Development Project & Portfolio Management for the Roche large and small molecule...Read more
This year the 2023 Spring Meeting and 19th Global Congress on Process Safety will hold a Poster Session and Reception in Houston, TX. The program will occur on Monday, March 13, 2023 from 5:00pm - 7:00 pm CT.
